Tags: colitis | nestle | drug

Colitis Relief: New Treatment Promotes Healing

Colitis Relief: New Treatment Promotes Healing
(Copyright AP)

Wednesday, 16 September 2015 11:19 AM EDT

Nestle is working with Lipid Therapeutics to develop and commercialize a new therapeutic treatment for mild-to-moderate ulcerative colitis, which can causes ulcers, bleeding and pain due to inflammation of the colon, the company said on Wednesday.

Nestle Health Science intends to develop an add-on therapy to an existing one that is commonly used but with which 40 percent of patients continue to experience flare-ups, the company said.

The LT-02 compound under development by Nestle can help to heal ulcers and restore lining of the colon wall, reducing chances of the condition returning.

The agreement is part of Nestle Health Science’s strategy to develop its product portfolio for gastrointestinal diseases, it said.

© 2024 Thomson/Reuters. All rights reserved.


Health-News
Nestle is working with Lipid Therapeutics to develop and commercialize a new therapeutic treatment for mild-to-moderate ulcerative colitis, which can causes ulcers, bleeding and pain due to inflammation of the colon, the company said on Wednesday. Nestle Health Science...
colitis, nestle, drug
111
2015-19-16
Wednesday, 16 September 2015 11:19 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved